4,048
Participants
Start Date
November 9, 2009
Primary Completion Date
January 10, 2011
Study Completion Date
February 1, 2011
GSK2340274A
One intramuscular injection
GSK2340273A
One intramuscular injection
GSK Investigational Site, Camillus
GSK Investigational Site, Binghamton
GSK Investigational Site, Erie
GSK Investigational Site, Rockville
GSK Investigational Site, Columbia
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Spartanburg
GSK Investigational Site, Jacksonville
GSK Investigational Site, DeLand
GSK Investigational Site, Delray Beach
GSK Investigational Site, Clearwater
GSK Investigational Site, Nashville
GSK Investigational Site, Lexington
GSK Investigational Site, Willoughby Hills
GSK Investigational Site, Chicago
GSK Investigational Site, Kansas City
GSK Investigational Site, Wichita
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Mesa
GSK Investigational Site, Los Angeles
GSK Investigational Site, Wenatchee
GSK Investigational Site, Milford
GSK Investigational Site, Somers Point
GSK Investigational Site, Warwick
GSK Investigational Site, Coquitlam
GSK Investigational Site, Bay Roberts
GSK Investigational Site, St. John's
GSK Investigational Site, Brampton
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, London
GSK Investigational Site, Ottawa
GSK Investigational Site, Toronto
GSK Investigational Site, Gatineau
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Sherbrooke
GSK Investigational Site, St-Romulad
Lead Sponsor
GlaxoSmithKline
INDUSTRY